Aethlon Medical Inc. stocks have been trading up by 8.29 percent after promising clinical development news boosted investor optimism. Key Takeaways Aethlon Medical will release its fiscal Q1 2026 results and host a conference call on 2026/08/13. The company is re‑highlighting its Hemopurifier

Aethlon Medical Inc. stocks have been trading up by 8.29 percent after promising clinical development news boosted investor optimism. Key Takeaways Aethlon Medical will release its fiscal Q1 2026 results and host a conference call on 2026/08/13. The company is re‑highlighting its Hemopurifier

View Aethlon Medical, Inc. AEMD stock quote prices, financial information, real-time forecasts, and company news from CNN.

Aethlon Medical Inc. stocks have been trading up by 28.99 percent amid heightened optimism over its latest therapeutic technology developments. Key Takeaways Aethlon Medical plans to release its fiscal Q1 2026 financial results and host a conference call on 2026/08/13. The company reiterated its

Aethlon Medical Inc. stocks have been trading up by 28.53 percent amid heightened investor optimism surrounding its therapeutic pipeline. Key Takeaways Aethlon Medical plans to release its fiscal Q1 2026 results and host a conference call on 2026/08/13. The company reiterated its strategic focus on the Hemopurifier device for treating cancer and life‑threatening viral infections.…

Aethlon Medical Inc. stocks have been trading up by 39.65 percent amid heightened investor optimism from recent company developments. Key Takeaways Aethlon Medical plans to release its fiscal Q1 2026 financial results and host a conference call on 2026/08/13. The company reiterated that its

Aethlon Medical Inc. stocks have been trading up by 8.29 percent amid heightened optimism from its latest therapeutic technology developments. Key Takeaways Aethlon Medical plans to release its fiscal Q1 2026 results and host a conference call on 2026/08/13. The company reaffirmed its focus on the Hemopurifier, a device targeting cancer and life‑threatening viral infections…

Aethlon Medical Inc. stocks have been trading up by 40.55 percent amid heightened investor optimism from recent company developments. Key Takeaways Aethlon Medical plans to release its fiscal Q1 2026 results and host a conference call on 2026/08/13. The company reiterated its strategic focus on the Hemopurifier device targeting cancer and life‑threatening viral infections. Aethlon’s…

Aethlon Medical Inc. stocks have been trading up by 32.3 percent following upbeat news driving renewed investor optimism. Key Takeaways Aethlon Medical will release its fiscal Q1 2026 financial results and host a conference call on 2026/08/13. The company reiterated its strategic focus on its Hemopurifier device, aimed at treating cancer and life‑threatening viral infections.…

Aethlon Medical Inc. stocks have been trading up by 8.76 percent after upbeat news on its therapeutic pipeline progress. What Traders Need To Know Aethlon Medical plans to release its fiscal Q1 2026 results and host a conference call on 2026/08/13. The company reiterated its strategic focus on the Hemopurifier device, aimed at treating cancer…